Cbl-b-IN-13
Cbl-b-IN-13 (Example 520) is a Cbl-b inhibitor with an IC50 of [1].
Product Specifications
CAS Number
2368841-85-2
UNSPSC
12352005
Target
E1/E2/E3 Enzyme
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cbl-b-in-13.html
Solubility
10 mM in DMSO
Smiles
O=C1C2=CC(CN3CCC4(CC4)C3)=CC(C(F)(F)F)=C2CN1C5=CC=CC(C6(CC7=NN=CN7C)COC6)=C5
Molecular Formula
C29H30F3N5O2
Molecular Weight
537.58
References & Citations
[1]Paul A. Barsanti, et al. Inhibitors of cbl-b and methods of use thereof. Patent WO2019148005A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-61744R-Cy5.5 100 µL
LOR/Loricrin Recombinant Antibody, Cy5.5 Conjugated
Sign In for Pricing
View Details 